TABLE 1.
Clinicopathological characteristics of 10 patients with glioblastoma.
| Patient number | Gender | Age | Treatment method | Treatment after surgery | Diagnosis time | Last treatment time | Max diameter (cm) | ECM1 IHC | MGMT | IDH1 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 77 | Sur | Un a | 2020.10.14 | 2021.02.24 | 5 | − | + | - |
| 2 | M | 68 | Sur | T + R | 2019.11.05 | 2020.09.23 | 6.5 | − | − | − |
| 3 | M | 76 | Sur | T + R | 2021.02.02 | 2021.04.09 | 6 | + | + | − |
| 4 | M | 67 | Sur | T + R | 2020.12.25 | 2021.09.05 | 1.2 | + | − | − |
| 5 | M | 48 | Sur | T + R | 2020.12.03 | 2021.09.06 | 7.5 | − | + | − |
| 6 | M | 64 | Sur | T + R | 2018.11.10 | 2020.01.22 | 3 | − | − | − |
| 7 | M | 69 | Sur | T + R | 2021.03.23 | 2021.08.30 | 5.2 | + | + | − |
| 8 | M | 70 | Sur | T + R | 2021.03.04 | 2021.08.12 | 5.5 | + | − | − |
| 9 | M | 63 | Sur | T + R | 2019.02.01 | 2021.09.06 | 5 | + | + | + |
| 10 | F | 65 | Sur | T + R | 2021.03.01 | 2021.08.09 | 5.7 | + | − | − |
F, female; M, male; MGMT, O-6-methylguanine-DNA methyltransferase; IDH1, isocitrate dehydrogenase 1 Sur, Surgery; Un, untreatment; T, temozolomide; R, radiotherapy.
a
The patients were intolerant to chemoradiotherapy.